Jazz Pharmaceuticals plc

JAZZ

$170.00

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,330,070,016.00

EPSttm : -6.14

Jazz Pharmaceuticals plc

$170.00

0.48%

$0.82

Float Short %

8.7

Margin Of Safety %

-8

Put/Call OI Ratio

0.32

EPS Next Q Diff

-2.65

EPS Last/This Y

-0.96

EPS This/Next Y

14.52

Price

169.99

Target Price

214.13

Analyst Recom

1.33

Performance Q

24.18

Relative Volume

0.31

Beta

0.27

Ticker: JAZZ

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-02	JAZZ	166.72	0.24	1.09	19006
2025-12-03	JAZZ	167	0.25	0.06	19093
2025-12-04	JAZZ	166.91	0.25	0.16	18988
2025-12-05	JAZZ	169.79	0.25	0.02	19103
2025-12-08	JAZZ	168.92	0.25	0.09	19274
2025-12-09	JAZZ	162.18	0.24	4.31	19404
2025-12-10	JAZZ	164.91	0.29	0.88	20180
2025-12-11	JAZZ	164.9	0.29	0.72	20389
2025-12-12	JAZZ	167.41	0.29	0.03	20373
2025-12-15	JAZZ	169.54	0.28	0.07	20505
2025-12-16	JAZZ	169.77	0.28	0.34	20740
2025-12-17	JAZZ	164.93	0.28	0.79	20430
2025-12-18	JAZZ	165.88	0.28	0.09	20409
2025-12-19	JAZZ	166.97	0.27	0.01	20482
2025-12-22	JAZZ	170.37	0.28	0.02	12352
2025-12-23	JAZZ	169.36	0.26	0.03	13197
2025-12-26	JAZZ	170.53	0.26	0.96	13352
2025-12-29	JAZZ	170.57	0.26	0.17	13385
2025-12-30	JAZZ	170.73	0.27	11.12	13142
2025-12-31	JAZZ	170.02	0.32	1.65	13669
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-02	JAZZ	166.71	-2.6	1693.0	8.11
2025-12-03	JAZZ	167.10	-2.6	1724.1	8.11
2025-12-04	JAZZ	166.93	-2.6	1721.1	8.11
2025-12-05	JAZZ	169.70	-2.6	1737.3	8.11
2025-12-08	JAZZ	168.94	-2.6	-	8.11
2025-12-09	JAZZ	162.26	-2.6	1685.5	8.11
2025-12-10	JAZZ	162.26	-2.6	1737.0	8.11
2025-12-11	JAZZ	164.89	-2.6	1721.5	8.11
2025-12-12	JAZZ	167.48	-2.6	1736.3	8.11
2025-12-15	JAZZ	169.53	-2.6	1733.1	8.11
2025-12-16	JAZZ	169.53	-3.1	1723.2	8.09
2025-12-17	JAZZ	165.07	-3.1	1696.8	8.09
2025-12-18	JAZZ	165.98	-3.1	1728.0	8.09
2025-12-19	JAZZ	166.99	-3.1	1727.4	8.09
2025-12-22	JAZZ	169.67	-3.1	1736.0	8.09
2025-12-23	JAZZ	169.59	-2.8	1720.7	8.10
2025-12-26	JAZZ	170.44	-2.8	1720.1	8.10
2025-12-29	JAZZ	170.50	-2.8	1722.1	8.10
2025-12-30	JAZZ	170.79	-2.8	1723.6	8.10
2025-12-31	JAZZ	169.99	-2.8	1717.5	8.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-02	JAZZ	-4.52	-3.72	8.35
2025-12-03	JAZZ	-4.52	-3.72	8.35
2025-12-04	JAZZ	-4.52	-3.72	8.35
2025-12-05	JAZZ	-4.48	-3.72	8.35
2025-12-08	JAZZ	-4.48	-1.71	8.35
2025-12-09	JAZZ	-4.48	-1.71	8.35
2025-12-10	JAZZ	-4.64	-1.71	8.58
2025-12-11	JAZZ	-4.65	-1.71	8.58
2025-12-12	JAZZ	-4.72	-1.71	8.58
2025-12-15	JAZZ	-4.72	-1.69	8.58
2025-12-16	JAZZ	-4.73	-1.69	8.58
2025-12-17	JAZZ	-4.69	-1.69	8.58
2025-12-18	JAZZ	-4.69	-1.69	8.58
2025-12-19	JAZZ	-4.69	-1.69	8.58
2025-12-22	JAZZ	-4.69	-1.73	8.58
2025-12-23	JAZZ	-4.69	-1.73	8.58
2025-12-26	JAZZ	-4.69	-1.73	8.70
2025-12-29	JAZZ	-4.69	-1.85	8.70
2025-12-30	JAZZ	-4.69	-1.85	8.70
2025-12-31	JAZZ	-4.69	-1.85	8.70
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

6.99

Avg. EPS Est. Current Quarter

6.41

Avg. EPS Est. Next Quarter

4.34

Insider Transactions

-4.69

Institutional Transactions

-1.85

Beta

0.27

Average Sales Estimate Current Quarter

1155

Average Sales Estimate Next Quarter

984

Fair Value

157.18

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.1

Max Drawdown 5-Year %

-47.5

Target Price

214.13

P/E

Forward P/E

7.57

PEG

1.24

P/S

2.48

P/B

2.61

P/Free Cash Flow

7.73

EPS

-6.07

Average EPS Est. Cur. Y

8.1

EPS Next Y. (Est.)

22.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.86

Relative Volume

0.31

Return on Equity vs Sector %

-36.6

Return on Equity vs Industry %

-21.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1717.5

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Jazz Pharmaceuticals plc

JAZZ

$170.00

Name : Jazz Pharmaceuticals plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,330,070,016.00

EPSttm : -6.14

Jazz Pharmaceuticals plc

$170.00

0.48%

$0.82

Float Short %

8.7

Margin Of Safety %

-8

Put/Call OI Ratio

0.32

EPS Next Q Diff

-2.65

EPS Last/This Y

-0.96

EPS This/Next Y

14.52

Price

169.99

Target Price

214.13

Analyst Recom

1.33

Performance Q

24.18

Relative Volume

0.31

Beta

0.27

Ticker: JAZZ

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-02	JAZZ	166.72	0.24	1.09	19006
2025-12-03	JAZZ	167	0.25	0.06	19093
2025-12-04	JAZZ	166.91	0.25	0.16	18988
2025-12-05	JAZZ	169.79	0.25	0.02	19103
2025-12-08	JAZZ	168.92	0.25	0.09	19274
2025-12-09	JAZZ	162.18	0.24	4.31	19404
2025-12-10	JAZZ	164.91	0.29	0.88	20180
2025-12-11	JAZZ	164.9	0.29	0.72	20389
2025-12-12	JAZZ	167.41	0.29	0.03	20373
2025-12-15	JAZZ	169.54	0.28	0.07	20505
2025-12-16	JAZZ	169.77	0.28	0.34	20740
2025-12-17	JAZZ	164.93	0.28	0.79	20430
2025-12-18	JAZZ	165.88	0.28	0.09	20409
2025-12-19	JAZZ	166.97	0.27	0.01	20482
2025-12-22	JAZZ	170.37	0.28	0.02	12352
2025-12-23	JAZZ	169.36	0.26	0.03	13197
2025-12-26	JAZZ	170.53	0.26	0.96	13352
2025-12-29	JAZZ	170.57	0.26	0.17	13385
2025-12-30	JAZZ	170.73	0.27	11.12	13142
2025-12-31	JAZZ	170.02	0.32	1.65	13669
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-02	JAZZ	166.71	-2.6	1693.0	8.11
2025-12-03	JAZZ	167.10	-2.6	1724.1	8.11
2025-12-04	JAZZ	166.93	-2.6	1721.1	8.11
2025-12-05	JAZZ	169.70	-2.6	1737.3	8.11
2025-12-08	JAZZ	168.94	-2.6	-	8.11
2025-12-09	JAZZ	162.26	-2.6	1685.5	8.11
2025-12-10	JAZZ	162.26	-2.6	1737.0	8.11
2025-12-11	JAZZ	164.89	-2.6	1721.5	8.11
2025-12-12	JAZZ	167.48	-2.6	1736.3	8.11
2025-12-15	JAZZ	169.53	-2.6	1733.1	8.11
2025-12-16	JAZZ	169.53	-3.1	1723.2	8.09
2025-12-17	JAZZ	165.07	-3.1	1696.8	8.09
2025-12-18	JAZZ	165.98	-3.1	1728.0	8.09
2025-12-19	JAZZ	166.99	-3.1	1727.4	8.09
2025-12-22	JAZZ	169.67	-3.1	1736.0	8.09
2025-12-23	JAZZ	169.59	-2.8	1720.7	8.10
2025-12-26	JAZZ	170.44	-2.8	1720.1	8.10
2025-12-29	JAZZ	170.50	-2.8	1722.1	8.10
2025-12-30	JAZZ	170.79	-2.8	1723.6	8.10
2025-12-31	JAZZ	169.99	-2.8	1717.5	8.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-02	JAZZ	-4.52	-3.72	8.35
2025-12-03	JAZZ	-4.52	-3.72	8.35
2025-12-04	JAZZ	-4.52	-3.72	8.35
2025-12-05	JAZZ	-4.48	-3.72	8.35
2025-12-08	JAZZ	-4.48	-1.71	8.35
2025-12-09	JAZZ	-4.48	-1.71	8.35
2025-12-10	JAZZ	-4.64	-1.71	8.58
2025-12-11	JAZZ	-4.65	-1.71	8.58
2025-12-12	JAZZ	-4.72	-1.71	8.58
2025-12-15	JAZZ	-4.72	-1.69	8.58
2025-12-16	JAZZ	-4.73	-1.69	8.58
2025-12-17	JAZZ	-4.69	-1.69	8.58
2025-12-18	JAZZ	-4.69	-1.69	8.58
2025-12-19	JAZZ	-4.69	-1.69	8.58
2025-12-22	JAZZ	-4.69	-1.73	8.58
2025-12-23	JAZZ	-4.69	-1.73	8.58
2025-12-26	JAZZ	-4.69	-1.73	8.70
2025-12-29	JAZZ	-4.69	-1.85	8.70
2025-12-30	JAZZ	-4.69	-1.85	8.70
2025-12-31	JAZZ	-4.69	-1.85	8.70
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

6.99

Avg. EPS Est. Current Quarter

6.41

Avg. EPS Est. Next Quarter

4.34

Insider Transactions

-4.69

Institutional Transactions

-1.85

Beta

0.27

Average Sales Estimate Current Quarter

1155

Average Sales Estimate Next Quarter

984

Fair Value

157.18

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.1

Max Drawdown 5-Year %

-47.5

Target Price

214.13

P/E

Forward P/E

7.57

PEG

1.24

P/S

2.48

P/B

2.61

P/Free Cash Flow

7.73

EPS

-6.07

Average EPS Est. Cur. Y

8.1

EPS Next Y. (Est.)

22.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-8.86

Relative Volume

0.31

Return on Equity vs Sector %

-36.6

Return on Equity vs Industry %

-21.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1717.5

Jazz Pharmaceuticals plc

Sector: Healthcare

Industry: Biotechnology

Employees: 2800

stock quote shares JAZZ – Jazz Pharmaceuticals plc Stock Price stock today

news today JAZZ – Jazz Pharmaceuticals plc stock forecast ,stock prediction 2023 2024 2025

marketwatch JAZZ – Jazz Pharmaceuticals plc yahoo finance google finance

stock history JAZZ – Jazz Pharmaceuticals plc invest stock market

stock prices JAZZ premarket after hours

ticker JAZZ fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: JAZZ

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y